cervical daysplasia.
Conditions
Interventions
Intervention 1: Intervention group:Patients in the intervention group take probiotic medication orally once a day for 12 weeks. Intervention 2: Control group:Patients in the control group take a place
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
25 Years to 50 Years
Inclusion criteria
Inclusion criteria: Women who have a positive HPV DNA Pap smear test
Exclusion criteria
Exclusion criteria: pregnancy Patients with congenital or acquired immunodeficiency
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in HPV infection after 6 months of patient follow-up. Timepoint: Checking HPV infection status through DNA testing at the beginning of the study, 6 months after the start of the study. Method of measurement: HPV testing via DNA testing. | — |
Secondary
| Measure | Time frame |
|---|---|
| Studying the prevalence of bacterial vaginosis in HPV-positive women. Timepoint: Clinical examination before and 6 months after the study. Method of measurement: Clinical examination.;The effect of probiotic consumption on improving bacterial vaginosis. Timepoint: Before and 6 months after the start of the study. Method of measurement: DNA test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarjan Ghaemibidgoli
Tehran University of Medical Sciences
Outcome results
None listed